Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
A simplified method of evaluating dose-effect experiments.
1948 • 7,047 citations
Molecular Mechanisms in the Receptor Action of Benzodiazepines
1979 • 579 citations
Epilepsy and γ-Aminobutyric Acid-Mediated Inhibition
1975 • 491 citations
Possible involvement of GABA in the central actions of benzodiazepines.
1975 • 346 citations
Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8)
1980 • 211 citations
Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)
1981 • 181 citations
Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum.
1975 • 141 citations
1-Methyl-?-carboline (Harmane), a potent endogenous inhibitor of benzodiazepine receptor binding
1980 • 119 citations
Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol
1981 • 109 citations
Anticonvulsant effects of caerulein and cholecystokinin octapeptide, compared with those of diazepam
1980 • 82 citations
Identification of harman in the rat arcuate nucleus
1980 • 61 citations
Differential cataleptogenic and antistereotypic effects of caerulein and haloperidol
1981 • 45 citations
Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS: distribution and possible physiological roles.
1980 • 40 citations
Anticonvulsant activity of muscimol against seizures induced by impairment of GABA-mediated neurotransmission
1979 • 30 citations
The role of gamma-aminobutyric acid in acute and chronic neuroleptic action.
1980 • 13 citations